Accepted for/Published in: JMIR Research Protocols
Date Submitted: Aug 8, 2025
Date Accepted: Oct 17, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Effects of Walnuts on Postprandial Cognitive Function in Adults with Subjective Cognitive Impairment: Protocol for a Randomized Crossover Trial
ABSTRACT
Background:
Subjective cognitive impairment, the earliest sign of cognitive decline, affects one in nine Americans over age 45. It negatively affects quality of life and is a risk factor for dementia. Healthy eating is a primary preventative strategy to impede cognitive decline. In the short term, cognitive function may be impacted by consumption of a single meal, suggesting that the meal components, and not solely the metabolic dysregulation resulting from the condition of obesity, can impact cognition. The effect of meals on postprandial cognitive function is influenced by their macronutrient composition. A meal with a low-quality fat composition can acutely impair postprandial cognitive function. Walnuts are a source of high-quality fat as well as polyphenols. Some randomized control trials have shown that walnuts may benefit cognitive function. However, it is not clear whether a single meal high in walnuts can improve cognition in adults with subjective cognitive impairment.
Objective:
The primary objective of the Essential Fats For Enhancing Cognitive Thinking (EFFECT) study is to determine the impact of walnuts on postprandial cognitive function in adults with subjective cognitive impairment. Secondary objectives include assessing the impact of daily walnut consumption for one week on cognitive function and erythrocyte fatty acids. Exploratory objectives include understanding the effect of walnut consumption on microbiota and intestinal inflammation.
Methods:
In this 7-week single-blind randomized crossover design study, 78 adults with subjective cognitive impairment will consume 1 study snack per day consisting of walnuts or a chocolate-style snack for 1 week with a 4-week washout period between. Before consuming each study snack, participants will undergo a meal challenge that includes the study snack. Prior to randomization, participants will complete a 1-week run-in period to become acclimated to consuming 1 study snack per day. A registered dietitian nutritionist will counsel participants on incorporating the study snack into their diet while maintaining their body weight. Participants will be blinded to which snack is the treatment and which is the control. Dietary intake and physical activity will be measured with 24-hour recalls. Cognitive function will be measured using the National Institutes of Health Toolbox for the Assessment of Neurological and Behavioral Function Cognitive Battery both pre and postprandially, as well as after 1 week of study snack consumption. Stool samples will be collected weekly, except during the washout period, to measure microbiota α-diversity, β-diversity and butyrate. Additionally, fasting blood samples, weight, and waist circumference will be obtained at each study visit.
Results:
Recruitment began in February of 2024 and will be completed by July 31, 2025.
Conclusions:
Improving cognition through consumption of walnuts may ultimately prove to be an effective way to mitigate subjective cognitive impairment. Clinical Trial: ClinicalTrials.gov NCT06223672; https://clinicaltrials.gov/study/NCT06223672
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.